Cargando…
Pembrolizumab-Induced Sarcoid-Like Reaction in a Patient With Lung Cancer
Cancer is not only the leading cause of mortality and morbidity but also poses a major economic burden. Until recently, onco-immunotherapy has dramatically changed the landscape of cancer treatment. For example, an inhibitor of programmed cell death (PD-1) plays a vital role by potentiating effectiv...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779128/ https://www.ncbi.nlm.nih.gov/pubmed/33409108 http://dx.doi.org/10.7759/cureus.12395 |